Meeting
2013 ASCO Annual Meeting
A comparative study of the response and toxicities in locally advanced head and neck cancer patients treated with paclitaxel, cisplatinum, 5-FU versus docetaxel, cisplatinum, 5-FU as neoadjuvant chemotherapy followed by concurrent chemoradiation.
Authors
Diptirani Samanta
Acharya Harihar Regional Cancer Centre, Cuttack, India
Diptirani Samanta , Surendra nath Senapati , Kirti Ranjan Mohanty , Saroj Das
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 6089)
DOI
10.1200/jco.2013.31.15_suppl.6089
Abstract #
6089
Poster Bd #
16E
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Phase I/II trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil (DCF) followed by concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
First Author: Hironaga Satake
Poster
2013 Gastrointestinal Cancers Symposium
Neoadjuvant DCF in resectable esophageal cancer: Single-center experience.
First Author: Vanita Noronha
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A randomized controlled phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced esophageal cancer with no pathological complete response: JCOG2206 (SUNRISE Trial).
First Author: Satoru Matsuda
Poster
2022 ASCO Annual Meeting
Phase 3 randomized study comparing docetaxel-platinum with docetaxel-platinum-5 fluorouracil as neoadjuvant chemotherapy in technically unresectable oral cancer.
First Author: Ajaykumar Singh